Stem Cell Theranostics Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Stem Cell Theranostics is a biotechnology research company focused on precision medicine for heart failure, developing genetically targeted therapies and accompanying translational preclinical models. Through an exclusive collaboration with the Stanford Cardiovascular Institute, it has established a discovery platform capable of guiding targeted therapies while simultaneously assessing cardiotoxicity, addressing the need for models aligned with a patient’s genetic profile. Headquartered in Redwood City, California, the firm operates in the biotechnology research sector and serves customers seeking advanced, genetically informed approaches to treating heart failure. The company situates itself within a landscape of specialized biotech firms focused on translating genetic insights into therapeutic strategies, leveraging its local academic partnership and research-centric, early-stage development capabilities.